Table 1: V31K^T against MRSA (SA 180-F Strain) shows ↓ (1 mg/mL).
- Measure
- qualitative
- Value
- ↓ (1 mg/mL)
- Target
- Staphylococcus aureus
- Assay
- Not reported by source
International Journal of Molecular Sciences · 2025
Sequence evidence
VTDFGVFVEIGGGGSRQIKIWFQNRRMKWKK
VTDFGVFVEIGGGGSRQIKIWFQNRRMKWKK
Experimental observations
Table 1: V31K^T against MRSA (SA 180-F Strain) shows ↓ (1 mg/mL).
Table 1: V31K^T against S. aureus (129B Strain) shows − (no decrease).
Table 1: V31K^T against E. coli (MG1655 Strain) shows − (no decrease).
Table 1: V31K^T against P. aeruginosa (2943 Strain) shows − (no decrease).
Table 2: V31K^T at 1 mg/mL against MRSA shows − (no inhibition zone).
Table 2: V31K^T at 0.1 mg/mL against MRSA shows − (no inhibition zone).
Table 2: V31K^T at 0.01 mg/mL against MRSA shows − (no inhibition zone).
Table 2: V31K^T at 0.001 mg/mL against MRSA shows − (no inhibition zone).
Table 2: V31K^T at 1 mg/mL against S. aureus 129B shows − (no inhibition zone).
Table 2: V31K^T at 0.1 mg/mL against S. aureus 129B shows − (no inhibition zone).
Table 2: V31K^T at 0.01 mg/mL against S. aureus 129B shows − (no inhibition zone).
Table 2: V31K^T at 0.001 mg/mL against S. aureus 129B shows − (no inhibition zone).
Table 2: V31K^T at 1 mg/mL against E. coli MG1655 shows − (no inhibition zone).
Table 2: V31K^T at 0.1 mg/mL against E. coli MG1655 shows − (no inhibition zone).
Table 2: V31K^T at 0.01 mg/mL against E. coli MG1655 shows − (no inhibition zone).
Table 2: V31K^T at 0.001 mg/mL against E. coli MG1655 shows − (no inhibition zone).
Table 2: V31K^T at 1 mg/mL against P. aeruginosa 2943 shows − (no inhibition zone).
Table 2: V31K^T at 0.1 mg/mL against P. aeruginosa 2943 shows − (no inhibition zone).
Table 2: V31K^T at 0.01 mg/mL against P. aeruginosa 2943 shows − (no inhibition zone).
Table 2: V31K^T at 0.001 mg/mL against P. aeruginosa 2943 shows − (no inhibition zone).
Table 3: V31K^T against MRSA early biofilm after crystal violet staining shows ↑ (reverse effect).
Table 3: V31K^T against S. aureus 129B early biofilm after crystal violet staining shows ↑ (reverse effect).
Table 3: V31K^T against E. coli MG1655 early biofilm after crystal violet staining shows ↑ (reverse effect).
Table 3: V31K^T against P. aeruginosa 2943 early biofilm after crystal violet staining shows − (no decrease).
Table 3: V31K^T against MRSA early biofilm after MTT assay shows ↑ (reverse effect).
Table 3: V31K^T against S. aureus 129B early biofilm after MTT assay shows ↑ (reverse effect).
Table 3: V31K^T against E. coli MG1655 early biofilm after MTT assay shows − (no decrease).
Table 3: V31K^T against P. aeruginosa 2943 early biofilm after MTT assay shows − (no decrease).
Table 4: V31K^T against MRSA mature biofilm after crystal violet staining shows − (no decrease).
Table 4: V31K^T against S. aureus 129B mature biofilm after crystal violet staining shows ↑ (reverse effect).
Table 4: V31K^T against E. coli MG1655 mature biofilm after crystal violet staining shows ↑ (reverse effect).
Table 4: V31K^T against P. aeruginosa 2943 mature biofilm after crystal violet staining shows ↑ (reverse effect).
Table 4: V31K^T against MRSA mature biofilm after MTT assay shows ↓ (0.01 mg/mL).
Table 4: V31K^T against S. aureus 129B mature biofilm after MTT assay shows − (no decrease).
Table 4: V31K^T against E. coli MG1655 mature biofilm after MTT assay shows − (no decrease).
Table 4: V31K^T against P. aeruginosa 2943 mature biofilm after MTT assay shows ↑ (reverse effect).
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.